丹麦献血者糖尿病诊断前的纵向代谢物与蛋白质轨迹:巢式病例对照研究
在丹麦献血者研究中,对324例新发糖尿病者和359例性别与出生年匹配的无糖尿病者最多11年随访的三次连续样本检测54种蛋白和171种代谢物及脂蛋白颗粒。发现诊断前有2种蛋白和16种代谢物及脂蛋白颗粒水平随时间变化,其中16种此前未描述;12种生物标志物加入临床信息与血糖后,10年糖尿病预测的AUC从0.79升至0.84。
要点
- 糖尿病诊断前数年即可检测到血浆分子标志物的时间依赖性变化。
- 2种蛋白和16种代谢物及脂蛋白颗粒水平在诊断前随时间变化,其中16种为新发现。
- 加入12种生物标志物使10年糖尿病预测AUC从0.79升至0.84。
核心结论
- 糖尿病诊断前数年血浆中已出现系统性分子变化,部分标志物呈现不同的时间依赖模式,具有作为糖尿病发病预测标志物的潜力。
研究设计与样本
- 巢式病例对照研究,纳入丹麦献血者研究(DBDS)中324例新发糖尿病者和359例无糖尿病者,按性别和出生年分布匹配,最多随访11年,每人三次连续样本,检测54种蛋白和171种代谢物及脂蛋白颗粒。
主要发现
- 鉴定出2种蛋白和16种代谢物及脂蛋白颗粒的水平在糖尿病诊断前随时间变化,且FDR校正后估计边际均值显著,其中16种此前未被描述。
- 另有75种生物标志物在糖尿病诊断前数年持续偏高或偏低。
- 1型糖尿病仅鉴定出单一时间标志物IL-17A/F,该细胞因子与多种其他自身免疫病相关。
- 与仅用临床信息和血浆葡萄糖相比,加入12种生物标志物改善了10年糖尿病诊断预测,受试者工作特征曲线下面积从0.79升至0.84。
临床怎么用
- 作者认为,这些生物标志物在1型和2型糖尿病之间呈现共享和不同的模式;在独立复制后,研究结果可用于开发新的临床预测模型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Metabolic risk factors and plasma biomarkers for diabetes have previously been shown to change prior to a clinical diabetes diagnosis. However, these markers only cover a small subset of molecular biomarkers linked to the disease. In this study, we aimed to profile a more comprehensive set of molecular biomarkers and explore their temporal association with incident diabetes. METHODS: We performed a targeted analysis of 54 proteins and 171 metabolites and lipoprotein particles measured in three sequential samples spanning up to 11 years of follow-up in 324 individuals with incident diabetes and 359 individuals without diabetes in the Danish Blood Donor Study (DBDS) matched for sex and birth year distribution. We used linear mixed-effects models to identify temporal changes before a diabetes diagnosis, either for any incident diabetes diagnosis or for type 1 and type 2 diabetes mellitus diagnoses specifically. We further performed linear and non-linear feature selection, adding 28 polygenic risk scores to the biomarker pool. We tested the time-to-event prediction gain of the biomarkers with the highest variable importance, compared with selected clinical covariates and plasma glucose. RESULTS: We identified two proteins and 16 metabolites and lipoprotein particles whose levels changed temporally before diabetes diagnosis and for which the estimated marginal means were significant after FDR adjustment. Sixteen of these have not previously been described. Additionally, 75 biomarkers were consistently higher or lower in the years before a diabetes diagnosis. We identified a single temporal biomarker for type 1 diabetes, IL-17A/F, a cytokine that is associated with multiple other autoimmune diseases. Inclusion of 12 biomarkers improved the 10-year prediction of a diabetes diagnosis (i.e. the area under the receiver operating curve increased from 0.79 to 0.84), compared with clinical information and plasma glucose alone. CONCLUSIONS/INTERPRETATION: Systemic molecular changes manifest in plasma several years before a diabetes diagnosis. A particular subset of biomarkers shows distinct, time-dependent patterns, offering potential as predictive markers for diabetes onset. Notably, these biomarkers show shared and distinct patterns between type 1 diabetes and type 2 diabetes. After independent replication, our findings may be used to develop new clinical prediction models.
引用
- Lundgaard AT, Westergaard D, Röder T, et al. Longitudinal metabolite and protein trajectories prior to diabetes mellitus diagnosis in Danish blood donors: a nested case-control study. Diabetologia. 2024. PMID: 39078488. doi:10.1007/s00125-024-06231-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。